Jul 6, 2026 08:33AM
May 21, 2026 05:02PM
May 13, 2026 08:03AM
May 12, 2026 09:30AM
May 8, 2026 08:45AM
Apr 23, 2026 08:27AM
Mar 27, 2026 04:03PM Moleculin Biotech (MBRX) files for 6.4M share offering by selling stockholders
Mar 23, 2026 08:33AM
Feb 19, 2026 08:39AM
Feb 18, 2026 08:20AM
Feb 13, 2026 08:35AM
Jan 13, 2026 08:55AM
Jan 12, 2026 08:37AM
Dec 23, 2025 04:49PM Moleculin Biotech (MBRX) files for 2.61M share offering by selling stockholders
Dec 10, 2025 08:30AM
Dec 8, 2025 08:21AM
Oct 29, 2025 08:35AM
Sep 10, 2025 07:33AM
Aug 13, 2025 07:11PM
Aug 6, 2025 08:42AM
Jul 30, 2025 08:35AM Moleculin receives notice for European patent on Annamycin preparation
Jul 22, 2025 08:40AM
Jul 9, 2025 08:37AM
Jun 20, 2025 09:20AM
Jun 18, 2025 07:30AM
Jun 9, 2025 06:14AM
Jun 4, 2025 08:46AM
May 14, 2025 04:30PM Moleculin Biotech (MBRX) Tops Q1 EPS by 209c
May 12, 2025 08:40AM
May 5, 2025 08:45AM
Apr 29, 2025 08:36AM
Mar 25, 2025 06:52AM
Mar 6, 2025 08:32AM
Mar 3, 2025 06:41AM
Feb 25, 2025 12:35PM Moleculin Biotech (MBRX) Announces Pricing of $3.5 Million Registered Direct Offering and Concurrent Private Placement Priced At The Market Under Nasdaq Rules
Feb 13, 2025 01:07PM
Feb 13, 2025 09:25AM
Feb 11, 2025 08:40AM
Nov 14, 2024 08:16AM
Nov 12, 2024 08:03AM
Aug 16, 2024 08:00AM
Aug 14, 2024 01:25PM Roth/MKM on Moleculin Biotech (MBRX): 'Undervalued Stock'
Aug 1, 2024 08:32AM
Jul 10, 2024 08:30AM
Jun 14, 2024 08:00AM

428,407 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All